Table 1 The patients’ clinical characteristics in both groups
Parameter | Group A N (%) | Group B N (%) |
|---|---|---|
Number of patients | 26 (65%) | 14 (35%) |
Number of CVCs insertions | 26 (56.5%) | 20 (43.5%) |
Rt. IJV | 26 (100%) | 14 (70%) |
Lt. IJV | — | 6 (30%) |
Indication for BMT | ||
Hematological diseases | 26 (100%) | 3 (21.4%) |
Beta Thalassemia major | 21 | — |
Acquired aplastic anemia | 2 | 2 |
Sickle-Thalassemia | 2 | — |
Mucopolysaccharaidosis | 1 | — |
Fanconi anemia | — | 1 |
Malignancies | — | 11 (78.6%) |
ALL | — | 6 |
AML | — | 3 |
Non-Hodgkin’s lymphoma | — | 2 |
Perioperative platelet transfusions | — | 20 (100%) |